Literature DB >> 8759823

Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy.

A Pfeufer1, K J Osterziel, H Urata, G Borck, H Schuster, T Wienker, R Dietz, F C Luft.   

Abstract

We examined the insertion/deletion polymorphism in the angiotensin-converting enzyme gene and identified polymorphisms in the heart chymase gene to test the hypothesis that these angiotensin II-producing enzymes are associated with a monogenic cardiac disease (50 patients and 50 control subjects) as a model of cardiac hypertrophy. We found that the angiotensin-converting enzyme DD genotype was present more often in patients than in control subjects and identified a possible interaction with 1 of the chymase polymorphisms.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8759823     DOI: 10.1016/s0002-9149(96)00296-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  15 in total

Review 1.  Modifier genes for hypertrophic cardiomyopathy.

Authors:  A J Marian
Journal:  Curr Opin Cardiol       Date:  2002-05       Impact factor: 2.161

2.  Elevated plasma chymotrypsin-like protease (chymase) activity in women with preeclampsia.

Authors:  Yuping Wang; Yang Gu; David F Lewis; J Steven Alexander; D Neil Granger
Journal:  Hypertens Pregnancy       Date:  2010       Impact factor: 2.108

3.  Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.

Authors:  J R Ortlepp; H P Vosberg; S Reith; F Ohme; N G Mahon; D Schröder; H G Klues; P Hanrath; W J McKenna
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

Review 4.  Role of renin-angiotensin system in gastric oncogenesis.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka; Naohito Shirai; Takahisa Furuta
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

5.  Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan.

Authors:  Mitsushige Sugimoto; Takahisa Furuta; Chise Kodaira; Masafumi Nishino; Mihoko Yamade; Mutsuhiro Ikuma; Haruhiko Sugimura; Akira Hishida
Journal:  J Gastroenterol       Date:  2008-10-29       Impact factor: 7.527

6.  Ten renin-angiotensin system-related gene polymorphisms in maximally treated Canadian Caucasian patients with heart failure.

Authors:  Marcin Zakrzewski-Jakubiak; Simon de Denus; Marie-Pierre Dubé; François Bélanger; Michel White; Jacques Turgeon
Journal:  Br J Clin Pharmacol       Date:  2008-02-12       Impact factor: 4.335

7.  RAAS gene polymorphisms influence progression of pediatric hypertrophic cardiomyopathy.

Authors:  Beth D Kaufman; Scott Auerbach; Sushma Reddy; Cedric Manlhiot; Liyong Deng; Ashwin Prakash; Beth F Printz; Dorota Gruber; Dimitrios P Papavassiliou; Daphne T Hsu; Amy J Sehnert; Wendy K Chung; Seema Mital
Journal:  Hum Genet       Date:  2007-09-13       Impact factor: 4.132

8.  Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.

Authors:  Christopher J McLeod; J Martijn Bos; Jeanne L Theis; William D Edwards; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Journal:  Am Heart J       Date:  2009-10-03       Impact factor: 4.749

9.  Progression of Left Ventricular Dysfunction and Remodelling under Optimal Medical Therapy in CHF Patients: Role of Individual Genetic Background.

Authors:  Marzia Rigolli; Mariantonietta Cicoira; Corinna Bergamini; Andrea Chiampan; Andrea Rossi; Corrado Vassanelli
Journal:  Cardiol Res Pract       Date:  2011-01-05       Impact factor: 1.866

10.  Impact of angiotensin I converting enzyme insertion/deletion polymorphisms on dilated cardiomyopathy and hypertrophic cardiomyopathy risk.

Authors:  Jianmin Yang; Yunhan Zhao; Panpan Hao; Xiao Meng; Mei Dong; Ying Wang; Yun Zhang; Cheng Zhang
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.